
Mesothelioma.net reviews the wide array of latest advances in treatment and care for patients affected by the challenging cancer as …

The December edition of Pharmafocus is live and available to read online now!Brexit continues to dominate the headlines inside and …

Bad news for Johnson & Johnson as it emerges that the US pharma giant has been ordered to pay out …

GSK is to back out of a licensing deal with California-based Five Prime Therapeutics to develop a mesothelioma drug. Announcing …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

